GL Engineering of East Hanover has been acquired by California-based SaniSure. With this acquisition, SaniSure will expand its global integrated offering of drug product fill and finish bioprocessing assemblies and solution.
GLE is a leader in filling needle design and manufacturing.
SaniSure will now be able to add new capabilities and manufacturing capacities for drug product filling needles and assemblies.
The acquisition complements each company’s technical capabilities, product offering and commercial reach. SaniSure has a direct sales force in the U.S. and Europe together with strategic regional distributors and manufacturer representatives.
“We are very excited about the addition of GLE to our innovative product portfolio,” SaniSure CEO Thomas Hook said. “GLE’s high-quality, global standards filling needle line represents an important expansion to SaniSure’s customer-focused solutions. Drug product filling solutions are a critical step in many of our customers’ processes. Having the ability to vertically integrate GLE’s solutions is quite unique,” Hook added.
Global demand for single-use technology is increasing rapidly with increasing research & development activities, a high level of biotech investments and strong global markets fueling a double-digit market growth rate.
“SaniSure’s assembly capabilities and commercial reach will significantly enhance the commercialization of our unique single-use needle design,” GL Engineering founder Gerhard Liepold said.
Liepold will now join SaniSure as the global product manager for drug product filling solutions.
